The company deployed four-quarter work
Release time:
2020-08-14
Company Deploys Fourth Quarter Work
News 10# July 16 and 17 , the company successively held work analysis meetings in the pharmaceutical sector, directly affiliated enterprises and cement sector to summarize and inventory the work in the third quarter and put forward requirements for the work in the fourth quarter. At the
analysis meeting, the heads of various enterprises reported on the work in the first three quarters of this year, especially the third quarter, focusing on analyzing the existing problems and proposing solutions and improvement plans. Chairman Jiang Xiaomeng, general manager Yu Jianhong and other group company leaders combined with the economic and technical data of each enterprise to comment on the work of each business sector one by one, pointed out the highlights of the work, analyzed the problems and deficiencies, and put forward guidance and work requirements.
Pharmaceutical sector: grasp the trend, strengthen cooperation, improve efficiency, innovate and break through the implementation of the "two-vote system" and "second bargaining" of
, which brings great pressure on drug sales. Company leaders require pharmaceutical companies to carefully study market trends from the perspective of strategic development and do a good job in the implementation of new products and projects, accelerate the research and development of new products such as DPT , production declaration and consistency evaluation, strengthen cooperation with relevant enterprises, and accelerate the promotion of new sales control models; at the same time, according to the actual situation of the enterprise, starting from the simplest management details, pay close attention to internal basic management, and promote the improvement of the overall quality and comprehensive management ability.
International Trade Company: Strengthen learning, strive for innovation, improve management
Company leadership requirements, international trade companies should seriously reflect on previous work, find problems from themselves, find gaps from the outside, strengthen the study of new ideas and concepts, find business operation modes with advantages and characteristics, and seek breakthroughs in logistics, distribution, warehousing, trade and other aspects, strengthen the management of internal resources, stock assets and workforce, control operating costs, and improve management and service levels.
Cable Company: Stabilize the team, improve management, and expand the market
Cable Company has been able to maintain the stability of production and operation and the workforce under the influence of many unfavorable factors in recent years, which has been unanimously affirmed by the company's leaders. The leaders of the company require the management cadres of the cable company to take the lead in setting an example, continuously improve their overall quality, continue to maintain the current good state, improve technology and management, and actively look for new businesses and new markets.
Peak Health: Looking for Advantages and Breakthrough
Company requires Peak Health Company to further clarify its working ideas in management, strive to find and build its own advantages, and consider future development in the long run. In terms of production, we should start with the purchase of raw materials and strengthen the source control of quality and cost. In terms of sales, efforts should be made to develop new customers and new markets, and strive to seek a breakthrough in enterprise management.
Cement Plate: Consolidate the foundation, in-depth optimization, and improve management standards
Company leaders pointed out that the two cement companies have maintained a good operating situation this year, with obvious results in technological transformation and job optimization, and job responsibilities Further clarification, labor productivity has been significantly improved, and market control capabilities have been improved, providing a reliable guarantee for profit growth. In the last few months of this year, the cement sector should take this good opportunity to further consolidate the foundation, strengthen management, maintain and improve cost advantages; continue to do a good job in marketing balance between varieties, regions, and between light and peak seasons, and strive to maximize benefits; Do a good job in equipment maintenance and technical transformation to keep the on-site equipment in good condition; accelerate the construction of "all-in-one card" to improve the level of management intelligence; continue to optimize positions on the existing basis, further improve work efficiency; further strengthen safety and environmental protection management, strengthen employee safety ideological education, and carry out in-depth and continuous self-inspection and self-correction of "anti-habitual violations" to ensure equipment operation and employee personal safety; further improve management standards and requirements, and do a good job All basic management work. (Reporter Fu Yiwu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31